Authors:
DRUSANO GL
DARGENIO DZ
SYMONDS W
BILELLO PA
MCDOWELL J
SADLER B
BYE A
BILELLO JA
Citation: Gl. Drusano et al., NUCLEOSIDE ANALOG 1592U89 AND HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE INHIBITOR 141W94 ARE SYNERGISTIC IN-VITRO, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2153-2159
Authors:
HUGHES W
DORENBAUM A
YOGEV R
BEAUCHAMP B
XU J
MCNAMARA J
MOYE J
PURDUE L
VANDYKE R
ROGERS M
SADLER B
Citation: W. Hughes et al., PHASE-I SAFETY AND PHARMACOKINETICS STUDY OF MICRONIZED ATOVAQUONE INHUMAN IMMUNODEFICIENCY VIRUS-INFECTED INFANTS AND CHILDREN, Antimicrobial agents and chemotherapy, 42(6), 1998, pp. 1315-1318
Authors:
LEE BL
TAUBER MG
SADLER B
GOLDSTEIN D
CHAMBERS HF
Citation: Bl. Lee et al., ATOVAQUONE INHIBITS THE GLUCURONIDATION AND INCREASES THE PLASMA-CONCENTRATIONS OF ZIDOVUDINE, Clinical pharmacology and therapeutics, 59(1), 1996, pp. 14-21
Authors:
LAVELLE J
TRAPNELL C
BYRNE R
NOBLIN J
SADLER B
BLUM R
ROGERS M
Citation: J. Lavelle et al., THE ABSOLUTE BIOAVAILABILITY OF ATOVAQUONE TABLETS AND SUSPENSION IN HIV-SEROPOSITIVE VOLUNTEERS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 192-192